Financial Reporting, Financial Statement Analysis and Valuation
Financial Reporting, Financial Statement Analysis and Valuation
8th Edition
ISBN: 9781285190907
Author: James M. Wahlen, Stephen P. Baginski, Mark Bradshaw
Publisher: Cengage Learning
bartleby

Videos

Textbook Question
Book Icon
Chapter 1, Problem 13PC

Value Chain Analysis and Financial Statement Relations. Exhibit 1.25 (page 68) presents common-size income statements and balance sheets for seven firms that operate at various stages in the value chain for the pharmaceutical industry. These common-size statements express all amounts as a percentage of sales revenue. Exhibit 1.25 also shows the cash flow from operations to capital expenditures ratios for each firm. A dash for a particular financial statement item does not necessarily mean the amount is zero. It merely indicates that the amount is not sufficiently large for the firm to disclose it. A list of the seven companies and a brief description of their activities follow.

  1. A. Wyeth: Engages in the development, manufacture, and sale of ethical drugs (that is, drugs requiring a prescription). Wyeth’s drugs represent primarily mixtures of chemical compounds. Ethical-drug companies must obtain approval of new drugs from the U.S. Food and Drug Administration (FDA). Patents protect such drugs from competition until other drug companies develop more effective substitutes or the patent expires.
  2. B. Amgen: Engages in the development, manufacture, and sale of drugs based on biotechnology research. Biotechnology drugs must obtain approval from the FDA and enjoy patent protection similar to that for chemical-based drugs. The biotechnology segment is less mature than the ethical-drug industry, with relatively few products having received FDA approval.
  3. C. Mylan Laboratories: Engages in the development, manufacture, and sale of generic drugs. Generic drugs have the same chemical compositions as drugs that had previously benefited from patent protection but for which the patent has expired. Generic-drug companies have benefited in recent years from the patent expiration of several major ethical drugs. However, the major ethical-drug companies have increasingly offered generic versions of their ethical drugs to compete against the generic-drug companies.
  4. D. Johnson & Johnson: Engages in the development, manufacture, and sale of over-thecounter health care products. Such products do not require a prescription and often benefit from brand recognition.
  5. E. Covance: Offers product development and laboratory testing services for biotechnology and pharmaceutical drugs. It also offers commercialization services and market access services. Cost of goods sold for this company represents the salaries of personnel conducting the laboratory testing and drug approval services.
  6. F. Cardinal Health: Distributes drugs as a wholesaler to drugstores, hospitals, and mass erchandisers. Also offers pharmaceutical benefit management services in which it provides customized databases designed to help customers order more efficiently, contain costs, and monitor their purchases. Cost of goods sold for Cardinal Health includes the cost of drugs sold plus the salaries of personnel providing pharmaceutical benefit management services.
  7. G. Walgreens: Operates a chain of drugstores nationwide. The data in Exhibit 1.25 for Walgreens include the recognition of operating lease commitments for retail space.

REQUIRED

Use the ratios to match the companies in Exhibit 1.25 with the firms listed above.

Chapter 1, Problem 13PC, Value Chain Analysis and Financial Statement Relations. Exhibit 1.25 (page 68) presents common-size , example  1Chapter 1, Problem 13PC, Value Chain Analysis and Financial Statement Relations. Exhibit 1.25 (page 68) presents common-size , example  2

Blurred answer
Students have asked these similar questions
VII. Direction: Compute and interpret. The following comparative financial statements are provided by Avatar Industries. You were asked to compute the different financial ratios and provide your interpretations with regards to profitability, efficiency, liquidity and solvency of the company. Use the Answer Sheet template below to input your answer and solution. AVATAR INDUSTRIES AVATAR INDUSTRIES Comparative Statement of Financial Position For the years 2019 and 2018 Comparative Income Statement For the years 2019 and 2018 2019 2018 2019 2018 ASSETS Current Assets: Sales P200,000 P210,000 Cash & Cash Equivalent P65,000 P70,000 Sales Returns and Allowances 40,000 25,000 Accounts Receivable 40,000 35,000 Net Sales 160,000 185,000 Marketable Secuities 40,000 35,000 Cost of Goods Sold 100,000 115,625 Inventory 100,000 80,000 Gross Profit 60,000 69,375 Total Current Assets 220,000 200,000 160,000 P445,000 P380,000 245,000 Operating Expenses: Fixed Assets Selling Expenses 22,000 25,000 Total…
VII. Direction: Compute and interpret. The following comparative financial statements are provided by Avatar Industries. You were asked to compute the different financial ratios and provide your interpretations with regards to profitability, efficiency, liquidity and solvency of the company. Use the Answer Sheet template below to input your answer and solution. AVATAR INDUSTRIES AVATAR INDUSTRIES Comparative Statement of Financial Position For the years 2019 and 2018 Comparative Income Statement For the years 2019 and 2018 2019 2018 2019 2018 ASSETS Current Assets: Sales P200,000 P210,000 Cash & Cash Equivalent P65,000 P70,000 Sales Returns and Allowances 40,000 25,000 Accounts Receivable 40,000 35,000 Net Sales 160,000 185,000 Marketable Securities 40,000 35,000 Cost of Goods Sold 100,000 115,625 Inventory 100,000 80,000 Gross Profit 60,000 69,375 Total Current Assets 245,000 220,000 Operating Expenses: Fixed Assets 200,000 160,000 Selling Expenses 22,000 25,000 Total Assets P445,000…
Specialty Department Stores chief executive officer (CEO) has asked you to compare the company's profit performance and financial position with the average for the industry. The CEO has given you the company's income statement and balance sheet, as well as the industry average data for retailers. Assets \table[[Current assets, %,.71.1%

Chapter 1 Solutions

Financial Reporting, Financial Statement Analysis and Valuation

Ch. 1 - Effect of Industry Characteristics on Financial...Ch. 1 - Effect of Industry Characteristics on Financial...Ch. 1 - Value Chain Analysis and Financial Statement...Ch. 1 - Starbucks The first case at the end of this...Ch. 1 - Starbucks The first case at the end of this...Ch. 1 - Prob. 1CICCh. 1 - Prob. 1DICCh. 1 - Starbucks The first case at the end of this...Ch. 1 - Prob. 1FICCh. 1 - Starbucks The first case at the end of this...Ch. 1 - Starbucks The first case at the end of this...Ch. 1 - Starbucks The first case at the end of this...Ch. 1 - Prob. 1JICCh. 1 - Starbucks The first case at the end of this...Ch. 1 - Starbucks The first case at the end of this...Ch. 1 - Prob. 1MICCh. 1 - Starbucks The first case at the end of this...Ch. 1 - Prob. 1OICCh. 1 - Starbucks The first case at the end of this...Ch. 1 - Starbucks The first case at the end of this...Ch. 1 - Prob. 1RICCh. 1 - Prob. 1SICCh. 1 - Starbucks The first case at the end of this...Ch. 1 - Prob. 1UICCh. 1 - Starbucks The first case at the end of this...Ch. 1 - Prob. 1WICCh. 1 - Prob. 2AICCh. 1 - Nike: Somewhere between a Swoosh and a Slam Dunk...Ch. 1 - Nike: Somewhere between a Swoosh and a Slam Dunk...Ch. 1 - Nike: Somewhere between a Swoosh and a Slam Dunk...Ch. 1 - Nike: Somewhere between a Swoosh and a Slam Dunk...Ch. 1 - Prob. 2FICCh. 1 - Prob. 2GICCh. 1 - Prob. 2HICCh. 1 - Prob. 2IICCh. 1 - Prob. 2JICCh. 1 - Prob. 2KICCh. 1 - Nike: Somewhere between a Swoosh and a Slam Dunk...Ch. 1 - Nike: Somewhere between a Swoosh and a Slam Dunk...Ch. 1 - Prob. 2NICCh. 1 - Prob. 2OICCh. 1 - Prob. 2PICCh. 1 - Prob. 2QICCh. 1 - Nike: Somewhere between a Swoosh and a Slam Dunk...Ch. 1 - Nike: Somewhere between a Swoosh and a Slam Dunk...Ch. 1 - Prob. 2TICCh. 1 - Nike: Somewhere between a Swoosh and a Slam Dunk...Ch. 1 - Prob. 2VICCh. 1 - Prob. 2WICCh. 1 - Nike: Somewhere between a Swoosh and a Slam Dunk...Ch. 1 - Prob. 2YICCh. 1 - Nike: Somewhere between a Swoosh and a Slam Dunk...Ch. 1 - Prob. 2AAICCh. 1 - Nike: Somewhere between a Swoosh and a Slam Dunk...Ch. 1 - Nike: Somewhere between a Swoosh and a Slam Dunk...Ch. 1 - Nike: Somewhere between a Swoosh and a Slam Dunk...Ch. 1 - Nike: Somewhere between a Swoosh and a Slam Dunk...
Knowledge Booster
Background pattern image
Finance
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, finance and related others by exploring similar questions and additional content below.
Similar questions
SEE MORE QUESTIONS
Recommended textbooks for you
Text book image
Financial Reporting, Financial Statement Analysis...
Finance
ISBN:9781285190907
Author:James M. Wahlen, Stephen P. Baginski, Mark Bradshaw
Publisher:Cengage Learning
Text book image
Financial Accounting Intro Concepts Meth/Uses
Finance
ISBN:9781285595047
Author:Weil
Publisher:Cengage
Financial ratio analysis; Author: The Finance Storyteller;https://www.youtube.com/watch?v=MTq7HuvoGck;License: Standard Youtube License